Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Landos Biopharma Inc | LABP | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
22,30 | 22,185 | 22,43 | 22,235 | 22,25 |
Actualités Recentes
Date | Heure | Source | Titre |
---|---|---|---|
25/3/2024 | 13:31 | PRNUS | AbbVie to Acquire Landos Biopharma, Further Strengthening.. |
25/3/2024 | 13:30 | GLOBE | AbbVie to Acquire Landos Biopharma, Further Strengthening.. |
04/3/2024 | 22:14 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
04/3/2024 | 22:06 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
14/2/2024 | 22:01 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
04/1/2024 | 14:05 | EDGAR2 | Form 8-K - Current report |
21/11/2023 | 14:08 | EDGAR2 | Form 8-K - Current report |
09/11/2023 | 14:22 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09/11/2023 | 14:08 | EDGAR2 | Form 8-K - Current report |
21/9/2023 | 14:00 | EDGAR2 | Form 8-K - Current report |
14/9/2023 | 14:11 | EDGAR2 | Form 8-K - Current report |
09/8/2023 | 14:18 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09/8/2023 | 14:12 | EDGAR2 | Form 8-K - Current report |